Latest Profitability News

Openn Negotiation Limited has reported a return to profitability for the year ended 30 June 2025, posting a total comprehensive profit of $412,860. The company will hold its Annual General Meeting in January 2026, with no dividends proposed.

4DMedical Limited has raised $150 million through a well-supported institutional placement to accelerate the commercialisation of its innovative lung imaging product CT – VQ™ in the US market. The capital raise comes with minimal dilution and increased insider confidence.

Beacon Minerals reported a solid December quarter with 7,310 ounces of gold produced and a 23% rise in realised gold prices, driving revenue to $53.47 million. The company is transitioning mining operations while maintaining strong recovery rates and shareholder returns.

Mirrabooka Investments reported a 93.6% jump in half-year profit to $8.9 million, maintaining its fully franked dividend despite portfolio returns trailing the small and mid-cap benchmark.

Articore Group reports solid progress in its turnaround strategy, showing margin expansion and a slowing decline in marketplace revenue for 2QFY26 and 1HFY26.

Oliver’s Real Food reported a remarkable 1926% increase in EBIT to $527k for the December 2025 quarter, despite a 7.7% revenue decline driven by strategic store closures. Same-store sales rose nearly 6%, underpinning a cautiously optimistic outlook.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.

Viking Mines reports promising high-grade tungsten oxide assay results from its Linka Tungsten Project in Nevada, reinforcing the project's potential amid soaring global scheelite prices.

Bluescope Steel has announced a special unfranked dividend of AUD 1.00 per share, payable in late February 2026, signaling a notable return to shareholders outside its regular dividend schedule.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.

The Calmer Co. International Limited has reported its highest ever monthly sales of $910,767 in December 2025, driven by strong wholesale growth and expanding US market presence.

AVITA Medical reported solid 11% revenue growth in 2025 and secured a $60 million credit facility to fuel its next phase of expansion, projecting up to 19% revenue growth in 2026.